| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 02/24/2005 | WO2005016876A2 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 02/24/2005 | WO2005016326A2 Analogs of thalidomide as potential angiogenesis inhibitors |
| 02/24/2005 | WO2005016264A2 Diamine derivatives of quinone and uses thereof |
| 02/24/2005 | WO2005016261A2 Aripiprazole and haloperidol pamoate salts |
| 02/24/2005 | WO2004096235A8 Anti-cancer phosphonate analogs |
| 02/24/2005 | US20050043552 Process for the synthesis of amine ethers from secondary amino oxides |
| 02/24/2005 | US20050043538 Peptide beta-strand mimics based on 1,2-dihydro-3(6H)-pyridinone |
| 02/24/2005 | US20050043388 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 02/24/2005 | US20050043354 Substance P antagonist |
| 02/24/2005 | US20050043316 Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 02/24/2005 | US20050043299 Inhibitors of dipeptidyl peptidase iv |
| 02/24/2005 | US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin |
| 02/24/2005 | DE19838666B4 Heterogenes Verfahren zur Herstellung von Enaminen, Iminen, Indolen und Diaminen aus Alkinen und Weiterverarbeitung der erhaltenen Produkte durch katalytische Hydrierung Heterogeneous process for the preparation of enamines, imines, indoles and diamines from alkynes and further processing of the products obtained by catalytic hydrogenation |
| 02/24/2005 | CA2534950A1 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 02/24/2005 | CA2529767A1 Aripiprazole and haloperidol pamoate salts |
| 02/24/2005 | CA2529750A1 N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| 02/23/2005 | EP1507826A2 Amelioration of the development of cataracts and other opthalmic diseases |
| 02/23/2005 | EP1507760A1 Cyanoguanidine prodrugs |
| 02/23/2005 | EP1507529A1 Combination of organic compounds |
| 02/23/2005 | EP1286986B1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 02/23/2005 | EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1585749A Cannabinoid receptor ligands |
| 02/23/2005 | CN1585748A NK1 antagonists |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1585640A N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 02/23/2005 | CN1583729A Method for synthetizing orixine and RU-19110 intermediate |
| 02/23/2005 | CN1190422C Prepn. process of nifedipine |
| 02/22/2005 | US6858747 Process to prepare, 1,4-dihydropyridine intermediates and derivatives thereof |
| 02/22/2005 | US6858738 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858639 3-Arylphenyl sulfide derivative and insecticide and miticide |
| 02/22/2005 | US6858628 Substituted cyclic amine metalloprotease inhibitors |
| 02/22/2005 | US6858626 Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 02/22/2005 | US6858623 Amidino and guanidino peptidyl compounds |
| 02/22/2005 | US6858434 Using thin layer chromatography for rapid preparation and screening of lead structures for drug candidates; rational drug design |
| 02/22/2005 | US6858018 Iontophoretic devices |
| 02/22/2005 | CA2093078C 2-substituted tertiary carbinol derivatives of 1,5-iminosugars |
| 02/22/2005 | CA2093077C 2- and 3-amino and azido derivatives of 1,5-iminosugars |
| 02/17/2005 | WO2005014571A1 Substituted piperidines as histamine h3 receptor ligands |
| 02/17/2005 | WO2005014526A1 Process for the hydrogenation of aromatic compounds |
| 02/17/2005 | WO2005013990A1 2-`4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3-yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 02/17/2005 | WO2005013988A1 2-`4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 02/17/2005 | WO2004110993A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | US20050038257 Process for preparation of benzylpiperidine compounds |
| 02/17/2005 | US20050038255 Stereoselective preparation of cyclic l-amino acids |
| 02/17/2005 | US20050038254 Efficient incubation preparation of such as terfenadine carboxylic acid metabolite |
| 02/17/2005 | US20050038100 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders; hyperphagia |
| 02/17/2005 | US20050038081 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide |
| 02/17/2005 | US20050038072 Nitrogeneous cyclic ketone derivative, process for producing the same, and use |
| 02/17/2005 | US20050038014 5'-carbamoyl-1,1' biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 02/17/2005 | US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy |
| 02/17/2005 | US20050035267 Furnace mount and method of installation |
| 02/17/2005 | US20050035266 Furnace Mount and Method of Installation |
| 02/17/2005 | DE10333588A1 Verfahren zur Hydrierung aromatischer Verbindungen A process for the hydrogenation of aromatic compounds |
| 02/17/2005 | CA2534101A1 2-`4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3-yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 02/17/2005 | CA2534096A1 2-`4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 02/17/2005 | CA2531796A1 Aryl and heteroaryl compounds, compositions, and methods of use |
| 02/16/2005 | EP1506961A2 Processes and intermediates for resolving piperidyl acetamide stereoisomers |
| 02/16/2005 | EP1506959A2 Derivatised molecules for mass spectrometry |
| 02/16/2005 | EP1506205A2 Novel azacyclic ethynyl derivatives |
| 02/16/2005 | EP1506173A1 Method for producing cyclic imides in the presence of polyphosphoric acid |
| 02/16/2005 | EP1506169A1 Method for the production of sulphamic acid halogenides |
| 02/16/2005 | EP1244617B1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 02/16/2005 | EP1215203B1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 02/16/2005 | EP0986540B1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers |
| 02/16/2005 | CN1582286A Novel 4-2-furoylaminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 02/16/2005 | CN1582274A Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 02/16/2005 | CN1189476C New thrombin inhibitors, their preparation and use |
| 02/16/2005 | CN1189466C New direct chain or cyclic urea, its preparing method and medicinal composition containing them |
| 02/16/2005 | CN1189458C Method for producing high purity antimer of (2s,3s)-1-tert-butoxy carbonyl-3-hydroxy-2-phenyl piperidine |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855832 O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/10/2005 | WO2005012248A1 Benzylamine derivative |
| 02/10/2005 | WO2005012244A1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same |
| 02/10/2005 | WO2005012228A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 02/10/2005 | WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor |
| 02/10/2005 | WO2005011611A2 Bicyclic compounds and compositions as pdf inhibitors |
| 02/10/2005 | WO2005011601A2 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders |
| 02/10/2005 | US20050032841 Enzyme inhibitors of ceramide glucosyltransferase or agents capable of increasing the rate of neuronal glycolipid degradation in treating of mucopolysaccharidosis diseases; e.g., N-butyldeoxynojirimycin and other imino sugars and genetic approaches; synergistic effect on activity of glucocerebrosidase |
| 02/10/2005 | US20050032837 For therapy of irritable bowel syndrome, drug addiction or dependency, including alcohol addiction, depression, anxiety, schizophrenia, anxiety, schizophrenia and eating disorders |
| 02/10/2005 | US20050032836 antipsychotic agents with a polylactide-co-glycolide extended release formulation; intramuscular or subcutaneous injections |
| 02/10/2005 | US20050032794 For example, 2-Dimethylamino-N-(3-dimethylamino-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-N-methyl-acetamide; ability to function as gene expression modulators for genes found in cancer cells, especially genes involved in misregulated signal transduction pathways typical of cancers of colon and breast |
| 02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | US20050032772 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/10/2005 | US20050028953 In bleaching plant; catalytic oxidation of pulp slurry, washing, stabilization |
| 02/10/2005 | CA2534473A1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same |
| 02/10/2005 | CA2534460A1 Benzylamine derivative |
| 02/10/2005 | CA2534127A1 Substituted benzothiophene compounds and uses thereof |
| 02/10/2005 | CA2533824A1 Bicyclic compounds and compositions as pdf inhibitors |
| 02/10/2005 | CA2533554A1 6-membered heteroaryl compounds for the treatment of neurodegenerative disorders |
| 02/09/2005 | EP1505199A1 Methods for making carboxylated pulp fibers |
| 02/09/2005 | EP1505066A1 Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic |
| 02/09/2005 | EP1503981A2 Substituted tetracycline compounds |